M u l t i p l e x  I H C 
Cell Phenotyping In Tumor Micro-environments


Immune Cell Phenotyping In Solid Tissues

Our approach is to allow different phenotypes to be visualized and quantified simultaneously in the same tissue section, enabling researchers to study the relationships and distribution of these cells within tumors and within the tumor micro-environment.
Using standard FFPE (Formalin-fixed, Paraffin-embedded) biopsies.


Work Flow For Multiplex IHC

 


S E R V I C E A B L E   M A R K E R

H U M A N

CD3, CD4, CD8, FOXP3, CD45RO, Granzyme B, CD20, CD56, CD57, CD14, CD15, CD16, CD11b, CD11c, CD66b, CD294, CD68, CD163, CD206, MHC-I, MHC-II, Ki-67, Pan-cytokeratin, TGFb, AFP, BCL2, CA9, CD103, CD86, E-Cad, EGLN1, Glut1, MAGE1, N-Cad, NKG2d, S100, TIM3, Vimentin, CD31, PD-1, PD-L1, CCR5, CCR7, CXCR5, DOG-1, GPC3, IDO, LAG3, SLAMF6, TERT, WT1, xCT, and etc.
Inquiry for other antibody settings

M O U S E

CD3, CD4, CD8, FOXP3, CD20, Granzyme B, PD-1, PD-L1, CD68, CD163, CD206, CD31, CTLA4, aSMA, PDPN, Ki-67, CD11b, CD11c, Gr-1, Caspase-3, CD19, CD73, CD86, INF-g, LYVE-1, and etc.
Inquiry for other antibody settings